The pharmaceutical industry has experienced significant growth over the past couple of decades, and there’s no indication that things will be slowing down any time soon. The already highly valuable industry is expected to have a CAGR of some 6.1% between now and 2030, culminating in an overall valuation of $2.3 trillion once the decade is out.
Of course, while the size of the pie may be large, that doesn’t mean that pharmaceutical companies can automatically expect to get their slice. The revenue will be reserved for the companies that proactively work on getting ahead. In this post, we’ll look at some of the most effective strategies that such companies can adopt to edge themselves ahead of their competitors.
Acquire a Competitor
Acquiring a competitor is a tried and tested method of growing market share. Though it’s rarely a realistic option to buy direct rival companies due to their size and valuation, it’s often possible to buy smaller, developing pharmaceutical companies that are showing early promise. This can give your brand access to innovative new products, additional infrastructure, exposure to new markets, and new talent, all of which can be fundamental for growth.
Invest in R&D
The leading pharmaceutical companies allocate a significant portion of their budget to research and development, sometimes as much as 25%. And you can understand why: in the best-case scenario, a single new product has the potential to generate billions in profits. Even mildly popular products can be a game-changer for a company’s outlook. Pharmaceutical companies that allocate funds to research aniracetam for memory enhancement purposes, or one of the many other nootropic substances, might just find that they have a viable product that goes on to become a hit. But before the rewards, there’s the R&D phase — it simply can’t happen without significant investment.
Expand Internationally
Entering a new market is a bit like acquiring a competitor: it can be a game-changer for the company’s fortunes, giving access to an entirely new audience. While this approach can be complicated due to different laws and regulations, those who do take the time to venture into new markets can find that it brings long-term advantages.
Invest in Regulatory Relationships
In many cases, it’s not the product itself that’s preventing the company from achieving success, but regulatory restrictions. It can take a long time to go through the regulatory process, yet companies can speed it up by proactively investing in their relationships with regulatory bodies. In doing so, they’ll find that they enjoy faster approval times, they can reduce development costs (since retrials won’t be necessary), and can just more quickly bring the product to market.
Quality Marketing and Sales Teams
Finally, just as with most other businesses, investing in high-level marketing and sales teams can help to improve the commercial side of your operations and increase sales. By taking the time to invest in talent for these areas, businesses can give themselves a competitive advantage and increase their chances of a new product becoming successful.
